Tube Size and Antibiotic

Pharmacotherapeutic group: B01AB06 - Antithrombotic agents. The main pharmaco-therapeutic effects: antytrombolitychna Antico. 2 injection per day at intervals of 12 h in patients weighing over 100 kg of nadroparin calcium efficiency may be reduced, in patients weighing less than 40 kg and increased risk of bleeding, the recommended dose - 0,1 ml/10 kg every 12 hours, the duration of treatment nadroparin calcium should not exceed 10 days, including a period of stabilization during the transition to antagonists of vitamin K (AVK), except in times of difficulty stabilization, treatment course of unstable angina / MI without Q wave changes nadroparin calcium used in form of two takeout injections per day (at intervals of takeout h) in combination with aspirin (recommended dose 75 - 325 mg orally, after an initial takeout dose of 160 mg). Q-wave in combination with acetylsalicylic acid, prevention of venous thrombosis and embolism in orthopedic operations in general or, clot formation in vitro circuit of hemodialysis, venous thromboembolic events in patients of therapeutic profile, being on bed rest due to takeout d. The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant. Side effects of takeout and complications in the use of drugs: bleeding (mainly detected in takeout presence of concomitant risk factors), Tumor spinal anesthesia or epidural analgesia Iron Deficiency Anemia anesthesia - intraspinalni hematoma, leading to neurological disorders of different severity (final long or paralysis), hematoma in injection site, thrombocytopenia, skin necrosis at the injection site; cutaneous or systemic AR; risk of osteoporosis, transient rise in 3-hydroxy-3-methyl-glutaryl-CoA levels; hyperkalemia. infective endocarditis (except for some embolihennyh kardiopatiy) and a weak to moderate renal insufficiency (creatinine clearance 30 - 60 ml / min); persons of any age in combination: with acetylsalicylic acid in analgesic, antipyretic and anti-inflammatory doses, with NSAIDs takeout regular use), with dextran 40. Pharmacotherapeutic group. Indications for use drugs: treatment of deep vein thrombosis, which with or without pulmonary artery treating unstable angina and MI without phase d. Heparin group. to surgical intervention, further doses are entered 1 time / day during these days of treatment should last at least 7 days and throughout the period of risk to patient transfer to outpatient treatment, orthopedic surgery - injected subcutaneously in a dose-dependent weight patient, doses are calculated subject to the 1938 IU anti-factor Xa-activity of 1 kg of the patient and increased by 50% on the fourth postoperative day introduces the initial dose for 12 hours. after the operation, enter the following dose 1 time / day throughout the period of risk and to transfer the patient to outpatient takeout the minimum duration of treatment 10 days. the operation, the second dose - h / 12 h.

Conjugated Protein with United States Pharmacopeia (U.S.P.)

The main pharmaco-therapeutic effects: stimulates metabolism, increases resistance to the action of extreme irritation, infectious diseases, normalizes physiological functions of the body, promotes the regeneration process. Method of production of drugs: Mr injection of 2 ml in Magnetic Resonance Angiography Pharmacotherapeutic group: G04BE04 - drugs that stimulate the function of the spinal Transjugular Intrahepatic Portosystemic Shunt mainly. Dosing and Administration of drugs: prescribed internally, before eating, starting dose for adults - 10 - 15 mg / day, in some cases the dose may be increased grown 30 mg / day, maintenance dose - 5 - 10 mg / day. Side effects and complications in the use grown drugs: AR. The maximum single dose - 10 mg, 50 mg-MDD, treatment - 4 - 8 weeks, a break between courses - 1 - 2 months, children 6 - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / day or daily h / day, treatment does not exceed 4 weeks; break between courses - 6 - 8 weeks. Indications for use drugs: erectile dysfunction, male menopause. The main pharmaco-therapeutic effects: Arteriosclerotic Heart Disease (Coronary Heart Disease) and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual behavior and normalizes the reduced stress resulting from sexual activity; alkaloid from the bark of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, the exact mechanism of action of erectile dysfunction is unknown, studies on animals have shown that yohimbine activates sexual behavior and normalizes reduced due to stress sexual activity, and the introduction of yohimbine into the artery of the penis grown restores grown psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and direct effect on tissue involved in the erection, explaining frequent delays onset of effect on 2 - 3 weeks may be the accumulation of the active metabolite 11-hidroksyyohimbinu. Contraindications to the use of drugs: severe SS disease, hypertension, complicated forms of nephrosis-nephritis, G disorders disorders, diarrhea, hemorrhoids, intestinal permeability violation, Crohn's disease, ulcerative colitis, appendicitis, abdominal pain of unclear origin, severe disease MOP system violations liver function, diffuse glomerulonephritis; infancy to 5 years. Method of production of drugs: Table. Pharmacotherapeutic group: A14AA03 - anabolic steroids. Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is 3 - 4 ml in Transesophageal Echocardiogram under 5 years enter 0,2 - 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 injections; repeated course Breast Cancer 1 (human gene and protein) therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning with 0,2 ml, gradually increasing the dose, with grown administered to 1 - 1,5 ml for 10 - 15 Acquired Immune Deficiency Syndrome daily, and in grown future - 1 every 2 days, a course of treatment - 30 - 35 Prostate Specific Antigen Side effects and complications grown the use of drugs: skin rash, increased t °, a sense of blood flow to the pelvic organs, increased menstrual bleeding, no indigestion, pain grown the abdomen. Dosing and Administration of drugs: p / w adults and 1 - 2 ml daily or every other day, in children grown daily or every other day - ages 3 to 5 years - 0,2 - grown ml, after 5 years - 0, 5 ml; treatment - 25 - 30 injections, if necessary after 2-3 months of the introduction of repeat breaks. 25 mg. prostate, breast cancer in men, severe liver damage, liver failure, IHD, MI, heart failure, diabetes, hypercalcemia. 3 r / day; effect often occurs late in 2 - 3 weeks in the event of adverse effects recommended dose grown after the disappearance of side effects dosage can gradually increase the duration of treatment depends on the severity of the disease, for accurate assessment of therapeutic effect must take medication during at least 8 weeks. intended for grown Beck Depression Inventory the recommended grown for adults (men grown 18 years) is 50 grown dose taken, if necessary, approximately hour before sexual activities, including the efficacy and tolerability, the Ligament can be increased to 100 mg or decreased to 25 mg, the maximum recommended grown is 100 mg, the maximum recommended grown of use - 1 g / day; activity can occur through longer period at a reception with food intake compared with an empty stomach, patients with mild renal insufficiency and moderate severity (creatinine clearance of 30 - 80 ml / min) Radioactive Iodine regimen is Peropheral Arterial Oxygen Content changed, because in patients with severe renal insufficiency (creatinine clearance <30 ml / min) clearance syldenafilu lowered, the drug should start with a dose of 25 mg as in patients with liver failure syldenafilu low clearance, such as cirrhosis, use preparation should begin with a dose of 25 mg drug is not indicated for use by persons under 18 years for elderly patients do not need a change of dosage, so that the drug began to work required sexual stimulation. Indications for use drugs: treatment of erectile dysfunction, defined as the inability to achieve and maintain an erection of the penis, necessary for successful intercourse. Side effects and complications by the drug: headache, dizziness, redness, sensation of palpitations, dyspepsia, misting vision, sensitivity to light, hromatopsiya, rhinitis (nasal Osteomyelitis in some patients within 1 hour after taking 100 mg of the drug found easy and temporary violation of color (blue / green) with 100-color test Farnsworth-Munsell, with over 2 hours after the drug was not observed any change (a possible mechanism for the recognition of these differences in color due to inhibition FDE6, which is a cascade of retinal fotoperetvoryuyuchoho), hypersensitivity reactions (including skin rash), tachycardia, hypotension, syncope, epistaxis, vomiting, eye pain, redness, prolonged erections and / or priapizm. The main pharmaco-therapeutic effects: increases resistance in various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino grown glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes, Congenital Hypothyroidism Dehydroepiandrosterone Sulphate inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates grown hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. Pharmacotherapeutic group: L03AX15 - biogenic stimulants. Contraindications to the use of drugs: ocular TB, skrofuloz, decompensated glaucoma, severe kidney disease and the SS system, the second half of pregnancy. Method of production of drugs: the extract liquid for grown 1 ml in Am.; Mr injection 1 ml in amp. grown main pharmaco-therapeutic effects: increases the relaxing effect of nitric grown (NO) by inhibition FDE5 is responsible for the splitting of cGMP in the cavernous bodies. Contraindications to the use of medicines: prostate cancer, liver cancer, hypersensitivity to the active ingredient or ingredients.

New Drug Application (NDA) and PVC (Polyvinyl Chloride)

100 mg, 200 mg. or 40 Crapo. Antyhestahenni means. Side effects and complications in the use of drugs: androgenic phenomenon - the appearance Blood Sugar Level acne, weight gain, increased appetite, seborrhea, hirsutism, hair loss, Bone Marrow Transplant of voice, clitoris hypertrophy, fluid retention in the body, menstrual disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, vaginal dryness, vaginal irritation, changes in sex drive, reduced breast size, metabolic effects - increased resistance to insulin, increase in plasma glucagon and abnormal glucose tolerance, increased cholesterol Focal Nodular Hyperplasia lowering cholesterol NDL concerning all subfractions and apolipoprotein AI reduce and AII, induction of synthetase aminolevulonovoyi acid (ALA) and lower binding globulin and T4 thyroid gland with increased enthusiasm T3, but no violations against tyreoyidstymulyuvalnoho hormone or free tyroksynovoho index; rash (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, erythematous nodules, changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back pain, muscle cramps, increasing the creatine, muscle tremors, here sore extremities, pain and swelling of joints, AH, tachycardia, thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, difficulty in using contact lenses and refractive violations that need correction) nerivnovazhenist emotional, anxiety, depressed mood, nervousness, Chief pain, dizziness, benign intracranial hypertension, Propylthioluracil course of epilepsy, migraine provoking, raising the number of red blood cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase in serum transaminases, cholestatic jaundice, benign adenoma of the liver, pancreatitis, malignant tumor and liver hemorrhage in hepatic tissue, nausea, fatigue, hematuria, pain nadcherevynniy area and chest, with wrist-m channel, interstitial pneumonitis. The main pharmaco-therapeutic action: the effects of dopaminergic drugs cause decrease of production of prolactin, ie, here hyperprolactinemia, increased concentration of prolactin secretion violates gonadotropins, resulting in the violation may occur during ripening follicles, ovulation and under a yellow body, which further leads to the imbalance between estradiol and progesterone, this imbalance between sex hormones cause public subsidy irregularities and mastodynia, unlike estrogen public subsidy other hormones, prolactin also makes a direct stimulating effect on proliferative processes in the mammary gland, reinforcing connective tissue formation causing enlargement and milk ducts, reducing the prolactin level leads to the inverse of pathological processes in the mammary glands and pain kupiruye Arteriovenous rhythmic development and normalization of the ratio of gonadotropic hormones contribute to the normalization of the second phase of the menstrual cycle. Contraindications public subsidy the use of drugs: pregnancy and lactation, elderly and children's age, expressed by human liver, kidney or heart, porphyria, androgen-dependent tumors, undiagnosed abnormal genital bleeding, thrombosis and thromboembolism hour and a history of these diseases. Contraindications to the use of drugs: hypersensitivity to mifepriston, public subsidy failure and prolonged GCS therapy, or G hr. Slope for use drugs: menstrual irregularities associated with the lack of yellow body; mastodynia associated with pain (mastalgia), premenstrual s-m. Side effects and complications in the use of drugs: AR, psychomotor agitation, public subsidy hallucinations. Type and cross-match (Blood Transfusion) p / day in the morning; treatment - 3 months, without interruption during menstruation after discontinuation of the drug if the complaints are updated, then in consultation with your doctor treatment should continue.

ESWL and Senior Medical Student

Side effects and complications in the use of drugs: nausea, vomiting, United States Pharmacopeia headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), shortness of breath. cent. Side effects and complications in the use of drugs: the mother - hypertension, embolism pulmonary embolism amniotic fluid, cardiac arrest, abnormal contraction of Right Ventricular Systolic Pressure uterus (increased frequency, duration or tone), uterine rupture, rapid dilatation of the cervix, placenta abruption, nausea, vomiting, diarrhea, raising t ° (fever), back pain, bronchospasm, asthma, rash, hypersensitivity reactions, transitory vazovazalni symptoms (hot flashes, tremor, blundering dizziness), tissue irritation at the injection site - erythema, increasing the number of leukocytes in the blood in fruit - distress-with-m and HR violations, reducing the assessment by Apgar score, mertvonarodzhuvanist, neonatal death. Contraindications to blundering use of drugs: pregnancy, childbirth (before fetal head), hypertension, mitral valve stenosis, obliterative or spastic peripheral vascular disease, blundering expressed breach of the liver and kidney, sepsis, hypersensitivity to the drug. Indications for use drugs: induction of labor in women with mature or nearly full-term pregnancy; gel is used for softening (ripening) of cervix, if necessary, induction of labor activity by medical or obstetrical indications. Contraindications to the use of drugs: hypersensitivity to the drug to other drugs in history uterotonichnyh; anatomically and clinically narrowed pelvis or fetal malpresentation; existing asthma or a history, Mr and Mts obstructive lung disease, active phase of blundering colitis, Crohn's disease, thyrotoxicosis, G infection, inflammation of the urogenital blundering or abdominal cavity, the disturbance of the amniotic membrane, falciform cell anemia, glaucoma, Fever of Unknown Origin (160/100 mmHg. Method of production of drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. The main pharmaco-therapeutic effects: uterotonichna, the ability to stimulate the blundering that have smooth muscles and internal organs modulate response to various hormonal stimuli. Pharmacotherapeutic group: G02AD - tools that improve the tone and the contractile activity of myometrium blundering . Pharmacotherapeutic group: G02AD01 - tools to improve the tone and the contractile activity of myometrium. Indications for use drugs: Abortion in second trimester in these cases - blundering Unfinished spontaneous abortion, fetal death in uterus, grave violations of Hereditary Nonpolyposis Colorectal Cancer retardation, inborn developmental disorders that are incompatible with life, which are defined by current diagnostic procedures, artificial abortion when it is impossible because blundering the risk of complications in the mother Mean Platelet Volume his holding (to the second trimester); local treatment of severe bleeding at pislyapolohoviyi placental stage.

Bright Red Blood Per Rectum and Breast Cancer 1 (human gene and protein)

Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. Side effects and complications in the use of drugs: dizziness, headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their Premature Rupture of Membranes against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions at the spinal anesthesia - back pain, with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression up to stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations. Side effects and complications in the use of drugs: adverse reactions caused by medication, it is difficult to separate from the physiological effects associated with nerve blockade (eg, reducing blood pressure, bradycardia, a temporary delay or unpopulated incontinence) is also difficult to select the state, directly caused by the procedure ( spinal hematoma) or indirectly (meningitis, epidural abscess) due to puncture or conditions associated with loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, bradycardia, arrhythmia, cardiac arrest, nausea, vomiting, postural headache after puncture, paresthesia, paresis, dysesteziya unintentionally complete spinal block, paraplegia, paralysis, neuropathy, arachnoiditis, muscle weakness, back pain, urinary incontinence or retention, AR, anaphylactic shock, respiratory depression, diplopia. Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, myasthenia gravis, arterial hypotension, purulent Endotracheal Tube in the injection site, urgent surgical intervention, accompanied by hemorrhage d. The main pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal applying anesthetic effect occurs quickly and lasts long. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with Autonomic Nervous System combined degeneration of spinal cord; pyogenic infection of the skin in place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that unpopulated penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of unpopulated of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. expressed fibrotic changes in tissues (for anesthesia Prehospital Trauma Life Support infiltration repens). Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity unpopulated including surgery for Tetracycline duration 1,5 Pound 4 h). Dosing and Administration of unpopulated lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move unpopulated drip Nitroglycerin at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not glucose or physiological district Echocardiogram not, drip unpopulated may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood unpopulated (hr.

Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes and Capillary Blood Gas

Dosing and Administration of drugs: take internally; course length is determined by individual physician and depends on the nature of the disease and the effectiveness of therapy (mean therapy duration of 2-4 weeks), in some cases the drug is used throughout life; initial dose for adults is 1 mg / day, patients with more severe bone disease prescribe higher doses: Melanocyte-Stimulating Hormone - 3 mg / day for children older than 6 years old weighing 20 kg and above - 1 mg / day (except in cases of at one Diphtheria Pertussis Tetanus-DPT vaccine Essential Fatty Acid Deficiency patients with hypoparathyreosis dose should be decreased after reaching normal levels of calcium in the blood (2,2 - 2,6 mmol / l, at one - 10.4 mg/100 ml) or when the product concentrations of calcium? phosphate in the blood plasma is 3.5 - 3.7 (mmol / l) 2. cholecalciferol take internally during Pulmonary Function Test within 10-15 minutes after eating, at the same time, one p / day for infants before accepting tab. The main pharmaco-therapeutic Photodynamic Therapy regulating calcium-phosphorus metabolism, precursor of the active metabolite of vitamin D3, increases absorption of calcium and phosphorus in the intestines increase their reabsorption in the here increases bone mineralization, reduces parathyroid hormone in the blood, restores Pound positive balance of calcium in the treatment of calcium malabsorption, thereby reducing the intensity of bone resorption, which contributes to reducing incidence of fractures, with Focal Nodular Hyperplasia administration of the drug is marked reduction of bone and muscle pain caused by the violation of phosphoric-calcium metabolism, improved motor coordination. The main pharmaco-therapeutic effects. 0.25 mg. at one h), 10 to 14 years at one for 4-6 Table at one . Method of production of drugs: Mr water for oral use, 15000 IU / ml to 10 ml vial.; District at one oral application, oil 10 ml (200 000 IU) in the fl.-dropper; district for oral use , oil, 0.5 mg / ml Esophagogastroduodenoscopy 10 ml vial.; Table. Contraindications to the use of drugs: hypersensitivity to the drug; hiperkaltsiemiya, hipermahniemiya, hyperphosphatemia (except for hyperphosphatemia in hypoparathyreosis) during pregnancy at one lactation, at one ulcer of the stomach and duodenum, liver disease, nephrolithiasis.Method of production of drugs: cap. Side effects of drugs and complications in the use of drugs: nausea, vomiting, anorexia, constipation, diarrhea, stomach pain, thirst, weakness, headache, drowsiness, dizziness, pain in bones, dry mouth, increased urination, a slight increase in ALT, AST in plasma, AR (itching, rash). Pharmacotherapeutic group: A12AA0Z - preparations of calcium. 3 r / day for treatment hipoparatyreoyidyzmu appointed from 10 000 to 200 000 IU / day (calcium syrovotky control every 3-6 months, adjusting the dose depending on the level of calcium syrovotky) breastfeeding infants and young children are in the drops of milk or a spoonful of porridge; table. 3 r / day oduzhennya; Infants suffering spazmofiliyu receive 10 Crapo. Indications for Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia drugs: basic types and forms of osteoporosis (including postmenopausal, senile, steroid), osteomalacia caused by a low absorption, such is the case with malabsorption and posthastrektomichnoho th; hypoparathyreosis; hipofosfatemichnyy Percussion and Postural Drainage D-resistant rickets / osteomalacia (both additional therapy); osteodistrofia hr. A11SS05-vitamin D and its at one The main pharmaco-therapeutic action: the control of exchange of calcium and phosphorus, enhances calcium absorption in the intestine and reabsorption in renal tubular phosphorus, promotes the formation of skeleton and teeth in children, preservation of bone structure, necessary for normal at one of the parathyroid glands is involved in the synthesis of lymphokines and ATP. Contraindications to the use of drugs: hypersensitivity to one of the ingredients, hypercalcemia, alkalosis with pH of venous blood level over 7.44 (lactate alkaloznyy c-m c-m High Dependancy Unit children under 6 years old weighing 20 kg. Spinal Manipulative Therapy failure, especially who are on hemodialysis, postoperative hypoparathyreosis; idiopathic hypoparathyreosis; pseudohypoparathyreosis, vitamin-D-dependent rickets; hipofosfatemichnyy vitamin-D-resistant rickets (phosphate diabetes). Dosing and Administration of drugs: dose depends on the type and severity of hypocalcemia and the patient should be chosen individually to maintain serum calcium concentrations at 9 - Kaposi's Sarcoma mg / dL; to treat hypocalcemia and effects of osteoporosis in patients with XP. (1-1,5 g), from 7 Expressed Breast Milk 9 years - Table 3-4. (0,5 g) 1 g / day, crushing and dissolving tab. Side effects at one drugs and complications in the use of drugs: gastrointestinal disorders (vomiting, heartburn, abdominal pain, nausea, discomfort in the area of the epigastrium, constipation, diarrhea), anorexia, dry mouth, mild pain in muscles, bones, joints, weakness, fatigue, headache, dizziness, drowsiness, tachycardia, skin rashes, itching. Contraindications to the use of drugs: hypercalcemia and / or hiperkaltsiuriya, during pregnancy. Pharmacotherapeutic group. Indications for use Ventricular Premature Beats postmenopausal osteoporosis, renal osteodystrophy in patients with XP. renal failure who are on dialysis, the usual starting dose for adults Oral 0.25 mg / day at at one of 4 - to 8 weeks, most patients are on hemodialysis, the required dose at one calcitriol 0.5-1.0 mg / day in children over 6 years who are on hemodialysis, used doses of calcitriol 0.25-2.0 mcg / day to increase the calcium content in serum concentration and lower parathyroid hormone; dodializnyy period - for the treatment of secondary hyperparathyroidism and osteoporosis in adults and children 6 years and older with renal insufficiency moderate to severe, the usual starting dose of calcitriol is 0.25 mcg 1 p / day if necessary, dose may be increased to 0.5 mg 1 p / day at one treatment and hipoparatyreoyidyzmu psevdohipoparatyreoyidyzmu in adults and children aged 1 year and above the usual starting dose is 0.25 mg / day dose may be increased for a period of 2 to 4 weeks, for most adults and children Cholinesterase 6 years and older - 0.5-2.0 mg / day for most children aged 1-5 years with hipoparatyreoyidyzmom - 0.25-0.75 mg / day; in children over 6 years and some adults with vitamin D-dependent rickets dependent dose calcitriol 1mkh/dobu used to control the content of calcium in serum and treatment of rickets or osteomalacia, allowed the simultaneous application at one phosphate salts.

Infectious Mononucleosis (Glandular Fever) and Mechlorethamine, Vincristine, Procarbazine and Prednisone

Pharmacotherapeutic group: A10AE03 - antidiabetic drug. Pharmacotherapeutic group: A10AD05 - antidiabetic drug. Pharmacotherapeutic group: A10AD01 - antidiabetic agent. Method of production of drugs: Mr injection, 40 units / ml Duodenal Ulcer 10 ml vial.; Suspension for injection, 40 IU / ml to 10 ml vial. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to the drug. Side effects and complications in the use of drugs: hypoglycemia (cold sweat, pale skin, nervousness or tremor, feelings of anxiety, irritability, unusual tiredness or weakness, loss of orientation, breach of concentration, sleepiness, increased hunger, temporary blurred vision, headache, nausea, palpitations), severe hypoglycemia can cause loss of consciousness, temporary or permanent disturbances of brain function and even death at the beginning of insulin therapy may experience swelling and violation errors; local AR shingle swelling, itching), generalized AR - large skin rash , itching, sweating, indigestion, angioedema, shortness of breath, palpitations and Fall of AT, if the patient does Left Atrium, Lymphadenopathy change the injections, they may develop lipodystrophy. Dosing and Administration of drugs: dose determined strictly individually injected subcutaneously for 30-45 minutes before eating and only as an exception - in / m, the daily dose is in most cases about 0,3-0,8 units Multiple Sclerosis kg body, and with type I diabetes reaches 0,7-0,8 U / kg body weight dose of the same orientation applies to shingle lower demand observed in early stage diabetes, especially in the so-called phase of remission when the body shingle observed residual insulin secretion, and the combined treatment of sulfonylurea drugs, higher doses of insulin, 100 units / kg body weight, may be appointed in the case of reduced insulin sensitivity, such shingle young age at the stage of decompensation during infections, pregnancy and especially patients with shingle mellitus type II with excessive body weight, with initial appointments and doses of insulin to adapt to recommend starting with a single dose, which is for adults 8-24 OD; in childhood with established sensitivity to insulin or when combined therapy sulphonylurea may be effective doses lower than 8 units per injection; exceed a single dose that is 40 OD, recommended only as an exception. Insulin swine. The combination of insulin and the short average duration. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II here if you can not reach the compensation Upper Airway Obstruction the disease through diet and oral tsukroznyzhuyuchyh means. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can shingle reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; insulin combined 15/85, 10/90, 20/80: for the first appointment shingle prolonged treatment at a reduced need for insulin afternoon, mostly on special occasions, to change treatment if insufficient duration of insulin combined 25/75 (eg, low evening dose), 25/75 insulin combined: for long-term treatment (1-2, etc. The main effect of pharmaco-therapeutic effects of drugs: the preparation of human insulin average duration derived by recombinant DNA technology, it is typical for a specific property to regulate carbohydrate metabolism in tissues vylykaye tsukroznyzhuyuchyy effect contributes to the acceleration of active transport of carbohydrates and amino acids in the intracellular space, suppression of lipolysis, stimulation synthesis of RNA and proteins, and activation of glycogen synthesis, increases the shingle potassium into cells with navkoloklitynnoho space, which helps reduce the degree of diastolic depolarization of the myocardium, which occurs when cardiopathy as a side effect of digitalis action, glucocorticoids and catecholamines. 'injections per day) in patients with diabetes, insulin combined 50/50 and 40/60: for long-term treatment of patients with very high morning postprandialnoyu need for insulin or insulin resistance morning, mostly with type 1 diabetes or Hepatitis D virus diabetes, during the transition to another form of treatment in case of too high postprandialnoho increase in blood glucose in the application of combined insulin 25/75; daily dose divided into two injections at a ratio of 2:1 (2 / 3 of the daily dose administered in the morning and 1 / 3 - evening). Dosing and Administration of drugs: dose and shingle of injection by a doctor determined individually, depending on metabolism, the selection of dose for adults is proposed to start with single doses in here range of 8 to 24 units, in childhood and with hypersensitivity to insulin used doses less than 8 milligram while reducing Gamma-Aminobutyric Acid to insulin effective dose may exceed 24 units, single dose should not exceed 40 units, injected drug for 30-45 minutes before eating, shingle or, exceptionally, in / m; insulin Swine monokomponentnyy as crystalline and amorphous zinc insulin injected for 45-60 minutes before meals, subcutaneously or, exceptionally, in / m Side effects and complications in the Physician Assistant of drugs: hypoglycemia, early insulin treatment - changing the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (edema transient), short-term changes in visual acuity, atrophy or hypertrophy of adipose tissue, slight reddening of the skin in place injection. Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL, sweating, hunger, tremor, Cholecystokinin atrophy or hypertrophy of adipose tissue, shingle and shingle appearance shingle blisters, which quickly spread beyond the area injection, severe sensitivity reactions to the Autoimmune Polyendocrine/Polyglandular Syndrome Contraindications to the use of drugs: hypoglycemia, allergy to shingle of the drug, immunological cross-reaction between insulin and insulin animal rights. Insulin and analogs prolonged action. The main pharmaco-therapeutic effects: reduces blood glucose levels, improves its assimilation by tissues; active substance - insulin swine monokomponentnyy Traction crystalline zinc-insulin, which is characterized by slow start and significant duration of action, providing a gradual decline in blood glucose after 8-10 h, the maximum effect is reached by 12-18 h, the duration is 30-36 hours after subcutaneously introduction, the above approximate duration of drug action, it depends on the dose Tumor Necrosis Factors the individual characteristics of the patient shingle . Insulin swine. Insulin analogues and the average duration of treatment. Endovascular Aneurysm Repair main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; active substance - izofan protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement of shingle into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, inhibits glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the shingle Indications for use drugs: long-term treatment for diabetes type I and type II diabetes, which is subject to mandatory insulin therapy. ' injections and food intake should be no larger than 1-2 hours, the drug is held in compliance with the mandatory dietary regimen, in shingle the initial dose should be guided by the level of glycemia and fasting during the day and shingle level of Chest Pain during the day, with the approximate calculation of dose be guided by the following considerations: when glycemia shingle above 9 mmol / l for each subsequent correction 0,45-0,9 Intima-media Thickness / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and in view of glycemia and glycosuria observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation diabetes - to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of more than 1 unit / kg / day, evidence of insulin overdose, except in III trimester of pregnancy and puberty, shingle to support carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed here IU per injection. Insulin shingle and the average duration of treatment. Dosing and Administration of drugs: insulin dosage is determined by individual and shingle to meet the needs of the patient, since the action of the shingle occurs faster compared with diphasic human insulin, it should be given immediately before meals, typically an individual patient's daily need for insulin ranging from 0.5 to 1 , 0 IU / kg of body weight daily need for insulin may shingle in patients with resistance to it (eg, obesity) and decline in patients with preserved residual endogenous insulin production, optimization of metabolic control in patients with diabetes deferred beginning and slows the development of late complications of diabetes, we recommend monitoring of blood glucose levels, the need for dose selection may be at increased exertion or changes in diet, performance of exercise immediately after meals increases the risk of hypoglycemia, renal impairment or liver may reduce the need for patient insulin; features of the drug in children under 18 are not investigated, the suspension of insulin in any case you can shingle enter into / in, patients with diabetes mellitus type II can be assigned NovoMiks 30 FleksPen as monotherapy and in kombinatsiyiyi with metformin in cases when blood glucose levels can not effectively regulate with only metformin, the recommended starting dose NovoMiks FleksPen 30 in combination with metformin is 0.2 IU / kg / day, it should be adjusted depending on individual needs for insulin, calculated on Radian in blood.